ArticleBiochemistry and biophysics reports2024

Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib.

Kai Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.